about
Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-AnalysisDynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencingrtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virusHepatitis B virus molecular biology and pathogenesisEfficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.Detection of hepatitis B virus genotypic resistance mutations by coamplification at lower denaturation temperature-PCR coupled with sanger sequencing.Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation.2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor.Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopmentEfficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysisGenotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy.Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine.Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis.Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis BOn-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis BComparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a systematic review and meta-analysisTenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failuresMutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy.Hepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar rats.Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series.The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-αEfficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovirHBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patientsRapid detection of hepatitis B virus variants associated with lamivudine and adefovir resistance by multiplex ligation-dependent probe amplification combined with real-time PCR.Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study).Entecavir for the long-term treatment of chronic hepatitis B.Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?Chronic viral hepatitis in kidney transplantation.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Recent advances in the treatment of chronic hepatitis B.
P2860
Q26765932-572B16DA-7313-40F4-9411-154124A71105Q28482355-90B05AE5-91B7-4C5C-AAFE-7632077FAF05Q28540082-CADAF9EB-AE3C-4B8C-99BF-0142C7C2EA1FQ28818406-524046B4-7BC7-43EC-B1C5-F037D507FC95Q30234870-2C31CE57-0005-410F-ABBD-2FE40F95FF9FQ33920626-A674B5E5-152E-497A-84D2-994A61AB2414Q33985364-9FEC8A1D-693D-4DB7-BC48-67EE4C6764B2Q34058707-A87A95E3-C115-403F-9F75-DE84A641A359Q34471072-DE3C9400-9E28-4B0C-AE74-30663CF2AB4BQ34594403-9772B7C1-47D3-4C67-9DD0-8A0EE7F53D5BQ34623662-6641BE18-9F2D-4D40-A7E1-F3A99AE9670AQ34948124-043C80E8-61F2-41A8-A0E3-62DFE311835FQ34995374-816E1315-5832-45DB-B9EF-BCCEA480CF86Q35076698-C7AE732C-8367-45F4-BEA9-8225B3E03CE2Q35077605-44F52DB8-1353-444D-99EF-3BFD3B650FDAQ35132805-40225798-EEBD-4342-9E0F-9132C5FAF451Q35186029-2DEC9A72-9E65-4164-AFF5-30F2F12DE799Q35375654-95E0B53A-8500-4593-81CD-7AAFEADC2E4AQ35540256-36473F96-90AA-413D-B3CE-100E4C307A41Q35694422-C5720B34-31DD-4662-AAC6-B620B173FE10Q35755608-A7745949-C15E-4F49-82C4-88DE2566D145Q35833216-22F0D71D-0585-45BB-9819-75E9ABA3DAAAQ36154994-6E424FCA-F594-4948-B2EA-EFF36396996AQ36238754-CDF2B5BA-2AAC-4C9E-9180-57E92A9F4191Q36325645-11C30641-C77D-4846-9422-F37F2D96BDDEQ36492635-B1D4928D-2054-4A7B-A9CA-1A4C7D44A5A6Q36492640-69EFFF53-6575-4F7E-B6B9-3F455ED15B48Q36566914-867249B8-CE9C-4D69-A728-C0DC47A012DDQ37034996-EC74FDA3-392C-499D-9CAD-4850FBCA8CB8Q37137734-BF076A3A-6F40-47B9-AAF3-960274A54D49Q37153828-75128DB6-C809-4B90-9DA6-C43B56A9535FQ37334120-7021393C-B636-4458-9120-F215B92EB622Q37409858-704F8BCB-61CB-438B-AFCF-BF37C1E08950Q37546232-7F25358E-02CE-44C8-8CBF-C9F48B62B3F3Q37606534-A90D4A65-E02A-42D5-B13D-9CC78CD1DC6EQ37626058-8356478F-6B93-44F8-B755-9ECDFE40EED3Q37825532-C2C6652D-A66A-4D77-98F5-2A46D059EFA4Q37833898-7641125B-6FEA-4540-95C3-20ACD1DFAFE4Q37886893-032ED9D7-61E0-4631-84E6-1E332EC39BECQ37891094-3CCAC28C-5C24-4E07-B065-D6F9218A8E70
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral resistance and hepatitis B therapy.
@en
Antiviral resistance and hepatitis B therapy.
@nl
type
label
Antiviral resistance and hepatitis B therapy.
@en
Antiviral resistance and hepatitis B therapy.
@nl
prefLabel
Antiviral resistance and hepatitis B therapy.
@en
Antiviral resistance and hepatitis B therapy.
@nl
P2860
P356
P1433
P1476
Antiviral resistance and hepatitis B therapy.
@en
P2093
Edward C Doo
Marc G Ghany
P2860
P304
P356
10.1002/HEP.22900
P407
P433
P577
2009-05-01T00:00:00Z